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Abstract
Objectives: The aim of this study was to investigate the
effects of antegrade balloon dilatation on ureteral
strictures that developed after kidney transplant.
Materials and Methods: The hospital databases of the
Erasmus Medical Center (Rotterdam, The Netherlands)
and the Academic Medical Center (Amsterdam, The
Netherlands) were retrospectively screened for patients
who underwent balloon dilatation after kidney
transplant. Balloon dilatation was technically
successful whenever it was able to pass the strictured
segment with the guidewire followed by balloon
inflation; the procedure was clinically successful if no
further interventions (for example, surgical revision of
the ureteroneocystostomy or prolonged double J
placement) were necessary.
Results: Fifty patients (2.4%) of 2075 kidney transplant
recipients underwent antegrade balloon dilatation
because of urinary outflow obstruction. Median time
between transplant and balloon dilatation was 3
months (range, 0-139 mo). In 43 patients (86%),
balloon dilatation was technically successful. In the
remaining 7 patients (14%), it was impossible to pass
the strictured segment with the guidewire. In 20 of 43
patients (47%) having a technically successful proce -
dure, the procedure was also clinically successful, with
median follow-up after balloon dilatation of 35.5
months (range, 0-102 mo). We did not identify any
patient or stricture characteristic that influenced the
outcome of treatment.
Conclusions: Balloon dilatation is a good option for
ureter stricture treatment after kidney transplant as it
is minimal invasive and can prevent surgical
exploration in almost 50% of cases.
Key words: Balloon dilatation, Kidney transplant,
Urinary outflow obstruction, Urologic complications 
Introduction
Major urologic complications after kidney transplant,
including urinary leakage and ureter strictures, are
reported with an incidence between 2.3% and 
20%.1-3 Ureteral strictures are the most commonly
reported urologic complication and can cause
significant morbidity after kidney transplant with
prolonged hospital stay and repetitive interventions.
A ureteral outflow obstruction is characterized by
elevated serum creatinine in combination with
hydronephrosis on ultrasonography examination
and is generally treated with a percutaneous ne h -
rostomy (PCN). In a number of cases, the obst ruction
will resolve spontaneously. However, in a few cases,
additional treatment is necessary to guarantee
adequate outflow.
Treatment options for ureteral strictures include
long-term double J catheter insertion, balloon dila -
tation, or surgical revision of the ureteroneo -
cystostomy. In the literature, only a few studies are
available that report on the success rates of these
treatments. Helfand and associates reported on their
experience with surgical treatment of ureteral strictures
after kidney transplant and proposed an algorithm for
management of strictures.4 The algorithm is based on
size of the stricture (< 3 cm) and the time between
transplant and diagnosis of the stricture (< 3 mo).
However, the study population was small (n = 13).4
Balloon dilatation has proven its efficacy in the
treatment of the ureterovesical junction for an
obstructive megaureter and in ureteroileal strictures 
of 1 cm or less in patients after surgical urinary
diversion.5-7
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The primary objective of this study was to present
a case series of balloon dilation treatment for
posttransplant ureteral strictures and to determine
its success rate. The secondary objective was to
determine which factors might be of influence on the
outcomes of balloon dilatation.
Materials and Methods
Patients
The Medical Ethical Committee approved the trial
protocol (MEC-2015-119). The hospital databases of
the Erasmus Medical Center (Rotterdam, The
Netherlands) and the Academic Medical Center
(Amsterdam, The Netherlands) were screened for
patients who underwent radiologic balloon
dilatation of the ureter after kidney transplant.
Baseline characteristics included recipient sex and
age, type of donor (deceased vs living), second warm
ischemic time, cold ischemic time, technique for
ureteroneocystostomy (intravesical vs extravesical),
number of prior transplant procedures, months
between kidney transplant and balloon dilatation,
stricture characteristics, readmissions within 1 month
after balloon dilatation, and follow-up in months
after balloon dilatation. Balloon dilatation was
considered technically successful if the interventional
radiologist was able to pass the strictured segment
with the guidewire and the balloon could be inflated.
Balloon dilatation was clinically successful if no
further interventions (for instance, surgical revision
of the ureteroneocystostomy or later prolonged
double J placement) were necessary. Graft survival
was based on the date a patient returned to
hemodialysis or peritoneal dialysis or received a
preemptive new transplant. All complications that
occurred within 30 days after balloon dilatation and
led to a readmission were documented. 
Diagnosing ureteral stricture
For all patients who presented with increased serum
creatinine and hydronephrosis on ultrasonography
examination, PCN placement was the first step in
treatment. Ureteral stricture diagnosis was confirmed
with anterograde pyelography. For this study, all
pyelograms were analyzed retrospectively for location
of the ureter stricture (proximal, midureteral, distal,
total, or multiple) and length of the stricture by 1
interventional radiologist (AM) with over 8 years of
experience in urogenital interventions. If the ureter
had multiple strictured segments, the length of the
longest stricture was documented.
Balloon dilatation procedure
The nephrostomy tube was replaced by an 8F
vascular sheath, and a 4F catheter with a hydrophilic
0.035-inch guidewire (Terumo, Belgium) was
introduced through the sheath into the renal pelvis
and ureter in antegrade fashion. The guidewire was
then passed through the strictured segment of the
ureter into the bladder, and a 3- to 8-mm-diameter
balloon was advanced over the guidewire and
inflated over several minutes. In cases where
traversing the stricture was difficult, smaller
diameter wires (0.014 inch) and balloons could be
used. The type of balloon varied over time between
a regular and a cutting balloon, which was at the
discretion of the treating interventional radiologist.
The cutting balloon has 3 or 4 microsurgical blades.
These blades are fixed longitudinally on the outer
surface of the balloon, expand radially, and deliver
longitudinal incisions in the strictured segment of the
ureter. After deflation of the balloon, a PCN, a
percutaneous nephroureterostomy (PCNU; Figure 1)
catheter, or a double J catheter was placed. 
Statistical analyses
Categorical variables are presented as numbers (with
percentages in parentheses). Continuous variables
are presented as median (range) if not normally
distributed; continuous variables with normal
distribution are presented as means with standard
deviation. Normality was based on the shape of the
histogram plot and tested with the Shapiro-Wilks
test. Categorical variables were analyzed using the
chi-square test. Continuous variables were analyzed
using the Mann-Whitney U test or an independent
t test. Graft survival was analyzed using a log-rank
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Figure 1. Balloon Dilatation and Percutaneous Internal/External
Nephroureteral Catheter
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test and censored for death. For graft survival, we
did not distinguish between technically or clinically
successful balloon dilatations. All technically and
clinically unsuccessful balloon dilatations were
considered as unsuccessful. All analyses were
conducted using IBM SPSS Statistics for Windows
(version 21.0; IBM Corp., Armonk, NY, USA). P < .05
(2-sided) was considered statistically significant.
Results
Baseline characteristics
The database analyses showed 50 patients who
underwent antegrade balloon dilatation (Table 1).
This included 37 patients (2.5 %) of 1496 kidney
transplants that were performed at Erasmus Medical
Center between August 2007 and September 2015. 
At the Academic Medical Center, 13 of 579 kidney
transplant patients (2.2%) patients underwent
balloon dilatation. The Academic Medical Center
database results included within a shorter period
(from March 2011 to June 2015). Median time
between kidney transplant and balloon dilatation
treatment was 3 months (range, 0-139 mo). The
median length of the total strictured segment 
was 2 cm (range, 0.5-5 cm), and median follow-up
after balloon dilatation was 35.5 months (range, 
0-102 mo). 
Balloon dilatation
In 43 of 50 patients (86%), balloon dilatation was
performed successfully from a technical point of
view. However, in 7 patients (14%), it was impossible
to pass the strictured segment with the guidewire. Of
these 7 patients, 2 patients had a second and even a
third attempt for balloon dilatation. These all
remained technically unsuccessful. In 20 of the 43
patients (47%) who underwent a technically suc -
cessful balloon dilatation, the procedure was also
clinically successful. Median follow-up after balloon
dilatation was 35.5 months (range, 0-102 mo). In 12
patients, balloon dilatation was clinically successful
after 1 attempt, 7 patients needed a second treatment,
and 1 patient needed 4 balloon dilatation treatments
before success was reached. These additional balloon
dilatation procedures were during a repeat pro -
cedure and not in the same procedure.
One patient with a technically successful
dilatation died from pneumosepsis (Pneumocystis
jiroveci) 1 month after balloon dilatation. This was
before stent removal; therefore, we were not able to
determine whether balloon dilatation was successful.
Another patient had a severe graft rejection after
balloon dilatation and graft nephrectomy was
necessary. In this case, we were also not able to
determine the success of balloon dilatation.
Therefore, in these 2 patients, the success was scored
as missing. One patient had a kidney infarction after
balloon dilatation, and this was scored as
unsuccessful. This event will be discussed further
below in the complications section.
Two patients underwent a surgical revision of the
ureterocystostomy before a successful balloon
dilatation. One of these patients received her
transplant in 2003 and had a surgical revision of the
ureteroneocystostomy in 2004. During this period, we
did not yet carry out balloon dilatations in our
hospital. In 2014, this patient had a recurrent stricture
and underwent successful balloon dilatation. The
other patient had urinary leakage that was primarily
followed by a surgical ureteral reconstruction 
2 days after transplant. This patient developed a
stricture that was successfully treated with balloon
dilatation. 
Of the 43 patients who underwent technically
successful balloon dilatation, a regular balloon was
used in 36 patients and a cutting balloon in 7 patients.
In 40 patients, the strictured segment was stented after
the balloon dilatation with a PCNU catheter or a
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table 1. Baseline Characteristics of 50 Study Patients
Population Characteristic
Number of male patients (%) 30 (60)
Mean age at kidney transplant ± SD, y 48 ± 16
Living donor, No. (%) 35 (70)
Median 2nd WIT, min (range) 26.5 (13-80)
Median CIT, min (range) 169 (96-2520)
Type of anastomose, No. (%)
Intravesical 10 (20)
Extravesical 34 (68)
Not documented 6 (12)
Primary reason for PCN, No. (%)
Hydronephrosis 43 (86)
Urinary leakage 7 (14)
Median number of transplants (range) 1 (1-4)
Median months between kidney transplant and BD (range) 3 (0-139)
Median length of longest stricture, cm (range) 1.5 (0.5-5)
Median length of total stricture, cm (range) 2 (0.5-5)
Location of stricture, No. (%)
Distal 33 (66)
Proximal 3 (6)
Midureteral 2 (4)
Total 6 (12)
Multiple 6 (12)
Median number of BD (range) 1 (1-4)
Technically successful BD, No. (%) 43 (86)
Clinically successful (of technically successful) BD, No. (%) 20 (47)
Median follow-up after BD, mo (range) 35.5 (0-102)
Abbreviations: BD, balloon dilatation; CIT, cold ischemic time; SD, standard
deviation; WIT, warm ischemic time
double J catheter; in the other 3 patients, a regular
PCN was placed and therefore scored as nonstented.
Twenty-six patients underwent surgical repair
after a balloon dilatation attempt. In 16 patients, the
strictured segment was resected and a new
ureteroneocystostomy was made. In 4 patients, the
native ureter was attached to the transplant renal
pelvis: 3 patients had a pyelocystostomy and 1
patient had the native ureter attached to the
transplanted ureter. During surgical exploration in 1
patient, the total ureter was strictured; therefore, no
further surgical options were available. This patient
remained nephrostomy dependent. In the last
patient, no ureteral obstruction was objectified
during surgical exploration; however, a limited
bladder capacity was detected and this patient was
treated with a suprapubic catheter. 
complications
In 1 patient, a kidney infarction was diagnosed 22
days after balloon dilatation treatment and 13 days
after PCN replacement. As kidney function
deteriorated, a biopsy was performed to exclude
rejection. Renal failure was attributed to loss of
parenchymal tissue secondary to infarction due to
vascular damage. The complication was not
attributed to balloon dilatation as such. However, the
intervention procedure was scored as clinically
unsuccessful in this case series.
One patient developed a ureter stricture of 1.5 cm
in the distal part of the ureter 3 months after
transplant. A PCN was placed, and a pyelogram was
made to visualize the pyeloureteral anastomosis.
During this procedure, a fistula between the renal
pelvis and iliac vein was visualized (Figure 2). It is
unknown whether it was present before or caused by
the intervention. The antegrade balloon dilatation
procedure was ended prematurely, ie, before entering
the bladder with the guidewire, and no ureteral
dilatation was performed. In the hours after the
procedure, the patient developed septic shock and
died despite antibiotic treatment. The cause of death
was explained by bacteremia due to direct circulatory
contamination with a multiresistant Escherichia coli in
an immunocompromised patient.
There were 23 patients without complications
who required readmission. Eighteen patients were
readmitted within 1 month because of urosepsis.
These readmissions could also be in conjunction with
chronic contamination due to continued PCNU or
PCN placement requiring a replacement of the
PCNU catheter or PCN. One patient was readmitted
because of the previously mentioned kidney
infarction, 1 patient was readmitted because of
hematuria with creatinine rise caused by an
obstructive blood clot, 1 patient was readmitted with
deep venous thrombosis, 2 patients were readmitted
for treatment of additional rejection, 3 patients were
readmitted because of PCN-related complications
(urinary leakage or dislocation), and 1 patient was
readmitted for diarrhea followed by urosepsis and
surgical revision of the ureteroneocystostomy. All of
these occurred within the first 30 days after the
procedure. In the patient with diarrhea, a perforation
of the ureter occurred while the radiologist tried to
pass the strictured segment with the guidewire. It
was impossible to pass the strictured segment, and
the procedure was ended prematurely. 
Graft survival
Graft survival was 100% at 12 months and 75% at 24
months after successful balloon dilatation. For the
unsuccessful procedures, graft survival was 92% at
12 and 24 months after attempting the balloon
dilatation (P = .937; Figure 3). Grafts failed due to
several causes, including 3 chronic failures followed
by preemptive retransplant in 2 patients, 2 acute
rejections, the previously mentioned kidney infarc -
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Figure 2. Pyelovenous Fistula
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tion, 1 recurrent primary disease (focal segmental
glomerulosclerosis), 1 case of glomerulosclerosis and
interstitial fibrosis, 1 case of cardiac shock with
subsequent contrast overload leading to acute
tubulus necrosis, and 1 case of urosepsis.
risk factor analyses
In univariate analysis, we found that donor
characteristics (type of donor, warm ischemic time,
cold ischemic time), type of ureteroneocystostomy
technique, recipient sex, months between kidney
transplant and balloon dilatation, type and diameter
of the balloon used, stricture length, stricture
location, and the use of a stent after balloon dilatation
were not factors that could influence the outcome of
the treatment (Table 2).
Discussion
Urologic complications, including urinary leakage
and ureteral strictures, may occur as early and as late
complications after kidney transplant. In this study,
we analyzed the outcomes of balloon dilatation as a
first treatment for ureter strictures after kidney
transplant. The technical success rate was 86%, and
the subsequent clinical success rate of balloon
dilatation treatment was 47%. We could not identify
any factors that may have contributed to a
(non)successful outcome of a balloon dilatation.
Several other studies have reported on outcomes
of balloon dilatation. Asadpour and associates
reported on 24 patients with ureteral strictures of
whom 11 (46%) had a successful outcome after
balloon dilatation and PCN treatment.8 Their results
are comparable to the outcomes of our present study.
Aytekin and associates9 reported a balloon dilatation
success rate of 90% in their cohort of 10 patients with
late obstructions due to strictures, which is a higher
success rate than shown in our cohort. Four patients
had a recurrence of the stricture; therefore, a repeated
balloon dilatation was necessary. In 2 of these patients,
a metallic stent was placed. In only 1 patient, surgical
revision of the ureterocystostomy after balloon
dilatation was necessary. It should be noted that, in this
study, a 7F double J catheter was inserted as standard
care after balloon dilatation. This might have increased
their success rate.9 On the other hand, Juaneda and
associates reported on 45 patients with ureteral
strictures with a 45% success rate in placing a double J
catheter after all balloon dilatations as well.10 In a
review by Haberal and associates, repeated balloon
dilatation in resistant strictures, a cutting balloon for
fibrotic strictures, and temporary postdilatation
double J stenting were also advised.11
He and associates tried to define a treatment
strategy for kidney transplant recipients who
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Figure 3. Graft Survival After Balloon Dilatation
table 2. Factors That May Contribute to Clinical Success of Technically
Successful Balloon Dilatation 
Factor Unsuccessful Successful P Value
Clinical Balloon Clinical 
Dilatation Balloon Dilatation
(n = 21) (n = 20)
Extravesical technique
ureteroneocystostomy, 
No (%) 16 (84) 12 (71) .326
Male recipient, No. (%) 14 (67) 10 (50) .279
Living donor, No. (%) 14 (67) 16 (80) .335
Median 2nd WIT, min (range) 24 (14-80) 25.5 (13-56) .886
Median CIT, min (range) 180 (96-1860) 156 (114-1260) 1.000
Median length of longest 
stricture, cm (range) 1.7 (0.5-5) 1.5 (0.5-5) .439
Longest stricture > 3 cm, 
No. (%) 5 (24) 2 (10) .240
Median months between 
kidney transplant and BD (range) 3 (0-139) 3 (0-135) .484
> 3 months between kidney 
transplant and BD 8 (38) 8 (40) .901
Location of stricture, No. (%)
Total 2 (10) 1 (5) .562
Proximal 2 (10) 1 (5)
Distal 12 (57) 15 (75)
Midureteral 2 (10) 0 (0)
Multiple 3 (13) 3 (15)
Type of balloon, No. (%)
Cutting 4 (19) 3 (15) .731
Regular 17 (81) 17 (85)
Diameter of balloon, No. (%)
3-4 mm 4 (19) 3 (15) .942
5-6 mm 7 (33) 7 (35)
7-8 mm 10 (48) 10 (50)
Stented postdilatation, No. (%) 20 (95) 18 (90) .520
Abbreviations: BD, balloon dilatation; CIT, cold ischemic time; SD, standard
deviation; WIT, warm ischemic time
Outcome data were missing for 2 patients. Univariate analysis was used.
develop ureteral obstruction. In their study, they
defined 3 grades of ureteral strictures: grade 1
included hydronephrosis without an evidently
strictured segment, grade 2 included hydronephrosis
with ≤ 1-cm strictured segment, and grade 3 included
hydronephrosis with > 1-cm strictured segment.12
They proposed the following treatment options:
grade 1 cases would receive prolonged stent
insertion for 6 weeks, grade 2 cases would receive
cystoscopy with incision or balloon dilatation
followed by stent insertion for 6 weeks, and grade 3
would have surgery. When we applied this
classification and treatment strategy to our cohort, 17
patients would fit the grade 2 classification; in 9 of
these patients, balloon dilatation was successful. In
our cohort, 33 patients had a stricture that could be
classified as grade 3 and would therefore benefit
from surgical treatment. However, 11 of these
patients had successful balloon dilatation and would
have been subjected to unnecessary surgical
intervention when following this classification.12
Based on the results of our cohort, we would advise
performing a balloon dilatation before surgical
revision, as it is less invasive, irrespective of the
proposed grading system.
There are some limitations to this study. Despite
our study including the highest number of balloon
dilatations reported until now, the total of 50 patients
is still low. Therefore, analyses of factors that could
contribute to the success rate of balloon dilatation
treatment cannot be performed reliably or perhaps
none of the factors influenced the outcome.
Furthermore, our treatment after balloon dilatation
was different in our patients. In some, the PCN drain
was left in situ; in others, the PCN was removed and
a single pigtail in PCNU position or a double J
catheter was placed instead. On the basis of the
available literature, double J catheter placement has
a favorable outcome; however, this would indicate
that an additional cystoscopy would be necessary to
remove the double J catheter.9,12 A drain in the PCNU
position would give the benefit of a stented stricture
postdilatation treatment, lacking the risks of an
additional cystoscopy.
We believe that balloon dilatation should be
advocated as the first treatment for ureter strictures.
It was clinically successful in 47% of patients, and it
is less invasive than open surgical ureter recon -
struction.
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